A13075
Size
  • 50ul
  • 100ul
Price
  • $129
  • $229
Qty
Add to Cart
Product description

disease:Antibodies against post-translationally modified DPYSL4, also called anti-CV2 autoantibodies, are present in sera from patients with paraneoplastic neurological diseases (PND). PND are disorders of the nervous system associated with various system

Source
Rabbit
Applications
WB,ELISA
Reactivity
Human,Mouse,Rat
Dilution
WB: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications.
Storage
-20°C/1 year
Specificity
CRMP-3 Polyclonal Antibody detects endogenous levels of CRMP-3 protein.
Source/Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogen
The antiserum was produced against synthesized peptide derived from human DPYSL4. AA range:91-140
Uniprot No
O14531
Alternative names
DPYSL4; CRMP3; ULIP4; Dihydropyrimidinase-related protein 4; DRP-4; Collapsin response mediator protein 3; CRMP-3; UNC33-like phosphoprotein 4; ULIP-4
Form
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Clonality
Polyclonal
Background
disease:Antibodies against post-translationally modified DPYSL4, also called anti-CV2 autoantibodies, are present in sera from patients with paraneoplastic neurological diseases (PND). PND are disorders of the nervous system associated with various system
Other
Gene_name: DPYSL4 ; Protein_name: Dihydropyrimidinase-related protein 4; Expression: Brain,Fetal brain,Retina,
Mol.Wt (Da)
62 kD
Concentration
1 mg/ml

  • Promotion

  • Order

  • Online message

  • Help center